AnGes

AnGes is a Japanese pharmaceutical company that was founded in 1999. The company focuses on the research and development of gene therapy-based drugs for the treatment of various diseases, including cancer, cardiovascular diseases, and genetic disorders. AnGes is known for its innovative work in the field of gene therapy, particularly in the development of therapeutic DNA vaccines and gene delivery technologies. Some of their notable drugs include HGF plasmid, which targets peripheral arterial disease, and BRITE, a DNA vaccine for cancer immunotherapy.